Article
Goodbye to Cheap Indian AIDS Drugs?
As India moves to meet a New Year's Day deadline to comply with the Trade Related Aspects of Intellectual Property Rights (TRIPS) regime of the World Trade Organisation (WTO) the cheap, generic anti-AIDS drugs that this country is famed for could be a thing of the past. [refers to Hetero Drugs, Ranbaxy Laboratories, Cipla]